368 related articles for article (PubMed ID: 16036527)
1. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
2. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.
Menchén L; Colón AL; Madrigal JL; Beltrán L; Botella S; Lizasoain I; Leza JC; Moro MA; Menchén P; Cos E; Lorenzo P
Am J Gastroenterol; 2004 Sep; 99(9):1756-64. PubMed ID: 15330915
[TBL] [Abstract][Full Text] [Related]
3. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
Dijkstra G; Moshage H; van Dullemen HM; de Jager-Krikken A; Tiebosch AT; Kleibeuker JH; Jansen PL; van Goor H
J Pathol; 1998 Dec; 186(4):416-21. PubMed ID: 10209492
[TBL] [Abstract][Full Text] [Related]
4. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
5. Role of alkaline phosphatase in colitis in man and rats.
Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G
Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260
[TBL] [Abstract][Full Text] [Related]
6. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
[TBL] [Abstract][Full Text] [Related]
7. Distribution of inducible nitric oxide synthase in ulcerative colitis.
Ikeda I; Kasajima T; Ishiyama S; Shimojo T; Takeo Y; Nishikawa T; Kameoka S; Hiroe M; Mitsunaga A
Am J Gastroenterol; 1997 Aug; 92(8):1339-41. PubMed ID: 9260802
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation.
McLaughlan JM; Seth R; Vautier G; Robins RA; Scott BB; Hawkey CJ; Jenkins D
J Pathol; 1997 Jan; 181(1):87-92. PubMed ID: 9072008
[TBL] [Abstract][Full Text] [Related]
9. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
[TBL] [Abstract][Full Text] [Related]
10. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity.
Vallance BA; Dijkstra G; Qiu B; van der Waaij LA; van Goor H; Jansen PL; Mashimo H; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G865-74. PubMed ID: 15217783
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
13. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
14. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
15. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
16. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
[TBL] [Abstract][Full Text] [Related]
17. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis.
Vento P; Kiviluoto T; Järvinen HJ; Soinila S
Scand J Gastroenterol; 2001 Feb; 36(2):180-9. PubMed ID: 11252411
[TBL] [Abstract][Full Text] [Related]
18. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
